QCM
EXAS

Qsemble Capital Management’s Exact Sciences EXAS Stock Holding History

Qsemble Capital Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-35,293
Closed -$1.88M – 504
2025
Q2 		$1.88M Buy
35,293
+30,006
+568% +$1.52M 0.18% 173
2025
Q1 		$229K Sell
5,287
-22,235
-81% -$1.13M 0.02% 398
2024
Q4 		$1.55M Buy
+27,522
New +$1.71M 0.21% 159
2024
Q1 		– Sell
-12,325
Closed -$912K – 451
2023
Q4 		$912K Buy
12,325
+6,625
+116% +$434K 0.23% 163
2023
Q3 		$389K Buy
+5,700
New +$484K 0.07% 271

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Qsemble Capital Management's EXAS Position: Q3 2025 in Review

Qsemble Capital Management sold out of Exact Sciences (EXAS) in Q3 2025, closing a stake of 35,293 shares — an estimated $1.88M sold.

Qsemble Capital Management first reported a position in EXAS in Q3 2023 and held it in 5 quarters. The position peaked at $1.88M in Q2 2025. 568 funds tracked by Wall St. Rank hold EXAS as of Q3 2025.

  • Qsemble Capital Management reported no remaining Exact Sciences position as of Q3 2025 after selling out during the quarter.
  • Qsemble Capital Management sold 35,293 Exact Sciences shares in Q3 2025, an estimated $1.88M.
  • Qsemble Capital Management first reported a position in Exact Sciences in Q3 2023 and held it in 5 quarters.
  • Qsemble Capital Management's Exact Sciences position peaked at $1.88M in Q2 2025.
  • 568 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2025.

Based on Qsemble Capital Management's 13F filing for Q3 2025, filed 13 Nov 2025.